NIH-funded research R01 grant

Integrating personalized skin cancer risk feedback in community health centers

Official title: A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers

Funded at H. Lee Moffitt Cancer Ctr & Res Inst · NIH-10936380 · Data updated 2026-11-12

This study is looking to help people understand their personal risk for skin cancer based on their genes, so they can make better choices about sun safety and skin checks, especially in community health centers.

More Skin Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionH. Lee Moffitt Cancer Ctr & Res Inst
NIH-funded
Lab location1 site (Tampa, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$706,771
NIH project number1R01CA291735-01
Project IDNIH-10936380 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults from diverse backgrounds who are at risk for skin cancer and receive care at community health centers.

Less likely to help

Patients who do not have access to community health centers or those who are not at risk for skin cancer may not benefit from this research.

What this research studies

This research aims to improve skin cancer prevention by providing personalized genetic risk feedback to diverse adult populations in federally qualified health centers. It focuses on educating patients about their risk factors related to skin cancer, particularly those linked to genetic variations. The study will evaluate how effectively this information can motivate individuals to adopt preventive behaviors, such as reducing sun exposure and increasing skin examinations. By engaging with community health settings, the research seeks to identify barriers and facilitators to implementing these interventions effectively.

Why it matters

Potential benefit: If successful, this research could lead to increased awareness and adoption of skin cancer prevention strategies among at-risk populations.

How similar studies have gone: Previous interventions using genetic risk feedback for skin cancer prevention have shown promising results, indicating that this approach has potential for success.

Where this research is happening

  • H. Lee Moffitt Cancer Ctr & Res Inst
    Tampa, United States
    Active

Researchers

  • Principal investigator: Kanetsky, Peter a — H. Lee Moffitt Cancer Ctr & Res Inst
  • Study coordinator: Kanetsky, Peter a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.